AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Bloomberg Businessweek
Illegal Ecstasy Takes Step Toward Becoming Legal Drug for PTSD
Jun 4, 2024
29:55
Snipd AI
Bloomberg News Consumer Reporter Tiffany Kary discusses MDMA's potential as a treatment for PTSD. Bloomberg Opinion Editor Mark Gongloff talks about global heating effects on temperatures. Bloomberg Intelligence Senior Semiconductor Analyst Kunjan Sobhani covers Intel's challenge to Nvidia in AI chip dominance.
Read more
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Ecstasy is making progress as a legal PTSD treatment, potentially revolutionizing psychiatric care.
- Intel targets Nvidia in AI chip competition, signaling advancements in semiconductor technology.
Deep dives
Potential Impact of MDMA as a PTSD Treatment
The podcast explores the FDA's review of a new drug based on MDMA to treat post-traumatic stress disorder (PTSD). If approved, the drug could be the first in over 20 years for PTSD. Some concerns involve running clinical trials with a control group when the effects of the drug are noticeable, challenging traditional trial standards. The potential approval holds significance for the 13 million PTSD sufferers, especially veterans. It could also set a precedent for the broader psychedelics industry, marking a new approach by the FDA.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode